Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP - Free Report) - Investment analysts at HC Wainwright decreased their FY2026 EPS estimates for Corbus Pharmaceuticals in a research note issued to investors on Tuesday, November 10th. HC Wainwright analyst A. Maldonado now expects that the biopharma